Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Spanish reimbursement system

Biogen Idec building

FDA approves Biogen Idec’s long-acting MS therapy

Plegridy gets US nod just weeks after EU approval

- PMLiVE

Valeant extends Allergan bid deadline to end of 2014

Acquisition saga carries on beyond original August 15 deadline

- PMLiVE

New York health department in HPV drive

New campaign will highlight the cancer-prevention benefits of the HPV vaccine

- PMLiVE

Alcon names president EMEA

Riad Sherif joins from Novartis’ Canada business

- PMLiVE

Acura must provide FDA more info on pain drug

Regulator questions abuse-resistant ability of Aversion

- PMLiVE

The death of traditional consumerism

What does it mean for pharma and how can empowering patients open up new possibilities to the industry

- PMLiVE

NICE backs Gilead’s Sovaldi in hepatitis C

But health watchdog denies earlier use of Janssen’s Zytiga

- PMLiVE

US panel backs pneumococcal vaccines for seniors

Vaccines to be provided by Merck & Co and Pfizer

- PMLiVE

Avastin gets US green light for late-stage cervical cancer

Fifth oncology indication for Roche’s medicine

- PMLiVE

Cancer Research UK calls for accuracy on Wikipedia

Appeals to healthcare community to keep online information up to date

- PMLiVE

GE Healthcare makes changes in Asia

Olivier Loeillot appointed general manager, Asia commercial for BioProcess division

- PMLiVE

Rebif hit again as competition bites

Merck Serono’s MS drug continues its struggle for sales in the US and Europe

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links